Literature DB >> 12176908

Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection.

Paul G Heyworth1, Deborah Noack, Andrew R Cross.   

Abstract

The p47-phox gene, NCF-1, has 2 nearly identical pseudogenes (psiNCF-1) in proximity at chromosomal locus 7q11.23. A dinucleotide deletion (DeltaGT) at the beginning of exon 2 that leads to a frameshift and premature stop codon is considered the signature sequence of the pseudogenes. It is also the most prevalent mutation in p47-phox-deficient (A47 degrees ) chronic granulomatous disease (CGD) as a result of the insertion of a DeltaGT-containing fragment of pseudogene into NCF-1. Extending our study of the relationship between NCF-1 and psiNCF-1 to 53 unaffected control individuals, we found that although in most (n = 44), the ratio of pseudogene (DeltaGT) to functional gene (GTGT) sequence in amplicons spanning exon 2 was 2:1, as previously observed, surprisingly, in 7 persons the ratio was 1:1, and in 2 persons the ratio was 1:2. The lowered ratios are explained by the presence, in a heterozygous or homozygous state, respectively, of a pseudogene that contains GTGT rather than DeltaGT. It is possible that this pseudogene has not undergone deletion of GT, but more likely, based on analysis of additional NCF-1/psiNCF-1 markers, it represents the previously unidentified product of the reciprocal crossover of DNA fragments between the functional gene and one of its pseudogenes. The mutated NCF-1 resulting from this event is the predominant A47 degrees CGD allele. The existence of 2 extended haplotypes encompassing NCF-1/psiNCF-1 further complicates the detection of A47 degrees CGD carriers. Although most have a DeltaGT/GTGT ratio of 5:1, some have a ratio of 2:1 and are indistinguishable by this means from unaffected individuals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176908     DOI: 10.1182/blood-2002-03-0861

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Williams syndrome predisposes to vascular stiffness modified by antihypertensive use and copy number changes in NCF1.

Authors:  Beth A Kozel; Joshua R Danback; Jessica L Waxler; Russell H Knutsen; Lisa de Las Fuentes; Gyorgy S Reusz; Eva Kis; Ami B Bhatt; Barbara R Pober
Journal:  Hypertension       Date:  2013-10-14       Impact factor: 10.190

2.  Approach to Molecular Diagnosis of Chronic Granulomatous Disease (CGD): an Experience from a Large Cohort of 90 Indian Patients.

Authors:  Manasi Kulkarni; Gouri Hule; Martin de Boer; Karin van Leeuwen; Priyanka Kambli; Jahnavi Aluri; Maya Gupta; Aparna Dalvi; Snehal Mhatre; Prasad Taur; Mukesh Desai; Manisha Madkaikar
Journal:  J Clin Immunol       Date:  2018-11-23       Impact factor: 8.317

3.  A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004-2017).

Authors:  Qinhua Zhou; Xiaoying Hui; Wenjing Ying; Jia Hou; Wenjie Wang; Danru Liu; Ying Wang; Yeheng Yu; Jingyi Wang; Jinqiao Sun; Qian Zhang; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2018-03-20       Impact factor: 8.317

4.  Mutational mechanisms of Williams-Beuren syndrome deletions.

Authors:  Mònica Bayés; Luis F Magano; Núria Rivera; Raquel Flores; Luis A Pérez Jurado
Journal:  Am J Hum Genet       Date:  2003-06-09       Impact factor: 11.025

5.  Clinical, Immunological, and Molecular Findings of Patients with p47phox Defect Chronic Granulomatous Disease (CGD) in Indian Families.

Authors:  Manasi Kulkarni; Mukesh Desai; Maya Gupta; Aparna Dalvi; Prasad Taur; Antony Terrance; Sunil Bhat; Mamta Manglani; Revathi Raj; Ira Shah; Manisha Madkaikar
Journal:  J Clin Immunol       Date:  2016-10-03       Impact factor: 8.317

Review 6.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome.

Authors:  Barbara R Pober; Mark Johnson; Zsolt Urban
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

7.  Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension.

Authors:  Miguel Del Campo; Anna Antonell; Luis F Magano; Francisco J Muñoz; Raquel Flores; Mònica Bayés; Luis A Pérez Jurado
Journal:  Am J Hum Genet       Date:  2006-01-31       Impact factor: 11.025

8.  A copy number variation in human NCF1 and its pseudogenes.

Authors:  Tiffany Brunson; Qingwei Wang; Isfahan Chambers; Qing Song
Journal:  BMC Genet       Date:  2010-02-23       Impact factor: 2.797

9.  Clinical and molecular features of 38 children with chronic granulomatous disease in mainland china.

Authors:  Huan Xu; Wen Tian; Shu-Juan Li; Lu-Ying Zhang; Wei Liu; Yao Zhao; Zhi-Yong Zhang; Xue-Mei Tang; Mo Wang; Dao-Qi Wu; Ji-Sheng Shi; Yuan Ding; Xiao-Dong Zhao; Xi-Qiang Yang; Li-Ping Jiang
Journal:  J Clin Immunol       Date:  2014-06-19       Impact factor: 8.317

10.  Lineage switching in acute leukemias: a consequence of stem cell plasticity?

Authors:  Elisa Dorantes-Acosta; Rosana Pelayo
Journal:  Bone Marrow Res       Date:  2012-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.